Management of Tirzepatide After Reaching Goal Weight
Evidence for Continued Therapy
- The American Diabetes Association recommends continuing weight management medications long-term unless clinical circumstances or other considerations suggest otherwise 1
- Sudden discontinuation of tirzepatide leads to substantial weight regain, with studies showing 50-67% of weight being regained within one year after stopping the medication 1, 2
Clinical Decision Algorithm
- For patients who have reached goal weight, the American Diabetes Association suggests continuing tirzepatide at the lowest effective dose that maintains the weight loss 1, 2
- Schedule follow-up visits at least quarterly to monitor weight maintenance and medication effectiveness, as recommended by the American Diabetes Association 1
Monitoring Recommendations
- After reaching goal weight, continue monitoring at least quarterly, as recommended by the American Diabetes Association 1
- Monitor for improvements in comorbid conditions, such as hypertension, dyslipidemia, and glycemic control 4
- Evaluate the need for adjustment of other medications that may have been prescribed for obesity-related conditions, according to the American Diabetes Association 5
Important Considerations and Pitfalls
- Discontinuing tirzepatide prematurely after reaching goal weight can lead to significant weight regain, as warned by the American Diabetes Association 1
- Women of reproductive potential must continue reliable contraception while on tirzepatide, as the medication is contraindicated in pregnancy, according to the American Diabetes Association 6